biote Corp. (BTMD) |
|
5 -0.12 (-2.34%)
|
10-02 16:00 |
|
Open: |
5.08 |
Pre. Close: |
5.12 |
|
High:
|
5.08 |
Low:
|
4.985 |
|
Volume:
|
92,555 |
Market Cap:
|
363(M) |
|
|
|
Technical analysis |
as of: 2023-10-02 3:48:23 PM |
|
Short-term rate:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 6.16 One year: 6.51 |
| Support: |
Support1: 4.78 Support2: 3.97 |
| Resistance: |
Resistance1: 5.27 Resistance2: 5.57 |
| Pivot: |
5.23 |
| Moving Average: |
MA(5): 5.25 MA(20): 5.17
MA(100): 5.85 MA(250): 5.12 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 36.1 %D(3): 53.6 |
| RSI: |
RSI(14): 39.8 |
| 52-week: |
High: 8.22 Low: 2.75 |
| Average Vol(K): |
3-Month: 157 (K) 10-Days: 77 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BTMD ] has closed above bottom band by 12.8%. Bollinger Bands are 54.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.21 - 5.24 |
5.24 - 5.27 |
|
Low:
|
4.99 - 5.04 |
5.04 - 5.08 |
|
Close:
|
5.05 - 5.12 |
5.12 - 5.17 |
|
Company Description |
|
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas. |
Headline News |
Sat, 16 Sep 2023
biote Corp. (NASDAQ:BTMD) Sees Significant Drop in Short Interest - MarketBeat
Thu, 10 Aug 2023
Biote Reports Second Quarter 2023 Financial Results - Yahoo Finance
Mon, 05 Jun 2023
Biote Announces Pricing of Secondary Offering of Common Stock - Business Wire
Tue, 30 May 2023
Biote Appoints Mary J. Puncochar as Chief Commercial Officer - Business Wire
Tue, 09 May 2023
Biote Announces Commencement of Exchange Offer and Consent ... - Business Wire
Mon, 07 Nov 2022
Biote Appoints Debby Morris to Board of Directors - citybiz
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: PNK |
| Sector: Healthcare |
| Industry: Medical Care Facilities |
| Shares Out. |
28 (M) |
| Shares Float |
16 (M) |
|
% Held by Insiders
|
16.3 (%) |
|
% Held by Institutions
|
71.4 (%) |
|
Shares Short
|
549 (K) |
|
Shares Short P.Month
|
990 (K) |
Stock Financials |
|
EPS
|
-0.41 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-1.67 |
|
Profit Margin (%)
|
-5.8 |
|
Operating Margin (%)
|
6.6 |
|
Return on Assets (ttm)
|
5.9 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
19.1 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
6.51 |
|
EBITDA (p.s.)
|
0.47 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
32 (M) |
|
Levered Free Cash Flow
|
-1 (M) |
Stock Valuations |
|
PE Ratio
|
-12.24 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-3.01 |
|
Price to Sales
|
0.76 |
|
Price to Cash Flow
|
4.31 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
